Parsippany, New Jersey December 17, 2021 — Edenbridge Pharmaceuticals, LLC today announced that it has received approval from the U.S. Food and Drug Administration on its 505(b)(2) New Drug Application (NDA) for Dartisla ODT (glycopyrrolate) orally…Original Article
FDA Approves Dartisla ODT (glycopyrrolate) for Use in the Treatment of Peptic Ulcer
